Adaptation of the STAIR-NT for First Responders

March 3, 2026 updated by: Joseph Schwartz, Florida State University

Adaptation of the STAIR-NT Intervention to Respond to Psychological Health Conditions for First Responders With a History of Traumatic Brain Injury

This study is a randomized controlled pilot examining the implementation of an adapted intervention, Skills Training in Affective and Interpersonal Regulation-Narrative Therapy (STAIR-NT), among a first responder population with a history of TBI and PTSD.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

The primary objective of the study is to implement and evaluate the effectiveness of an evidence-based intervention, STAIR-NT, which will be adapted with Goal Management Training (GMT). A small-scale randomized control pilot will be conducted using the adapted intervention to examine implementation (i.e., feasibility, acceptability) and improvements in short-term PTSD, as well as secondary mental health outcomes (e.g., anxiety, and depression symptoms, substance misuse) among a first responder population with a history of TBI and PTSD.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Tanya Renn, PhD
  • Phone Number: 850-645-0903
  • Email: trenn@fsu.edu

Study Contact Backup

Study Locations

    • Minnesota
      • Forest Lake, Minnesota, United States, 55025
        • Invisible Wounds Project
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years or older
  • be a first responder within the state of Minnesota
  • have a history of a TBI
  • screen for PTSD.

Exclusion Criteria:

  • Does not meet inclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adapted STAIR-NT Intervention
Participants in this arm will receive the adapted version of Skills Training in Affective and Interpersonal Regulation-Narrative Therapy (STAIR-NT).
An adapted version of STAIR-NT that utilizes components from GMT in order to treat PTSD and TBI.
Other Names:
  • Skills Training in Affective and Interpersonal Regulation with Narrative Therapy
No Intervention: Treatment as usual (TAU)
Participants in this arm will receive treatment as usual.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Post-Traumatic Stress Disorder Symptoms
Time Frame: Baseline, 4-6 weeks, 3 months, 6 months
The 20-item PTSD Checklist for DSM-5 (PCL-5) will be used to assess PTSD symptoms. All items are scored on a 5-point Likert scale ranging between 0 (not at all) and 4 (extremely).
Baseline, 4-6 weeks, 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Anxiety Symptoms
Time Frame: Baseline, 4-6 weeks, 3 months, 6 months
The Generalized Anxiety Disorder Screener-7 (GAD-7) will be used to assess anxiety symptoms. The included items ask participants to indicate how frequently they experienced seven symptoms over the past two weeks, with provided response categories ranging between 0 (not at all) to 3 (nearly every day).
Baseline, 4-6 weeks, 3 months, 6 months
Change in Depression Symptoms
Time Frame: Baseline, 4-6 weeks, 3 months, 6 months
The Patient Health Questionnarie-9 (PHQ-9) is an abbreviated version of the full PHQ focused on major depressive disorder and will be used to assess depression symptoms. Participants are asked to indicate how often they experienced nine different feelings over the past two weeks with possible response categories ranging between 0 (not at all) and 3 (nearly every day).
Baseline, 4-6 weeks, 3 months, 6 months
Change in Alcohol Use
Time Frame: Baseline, 4-6 weeks, 3 months, 6 months
The Alcohol Use Disorders Identification Test (AUDIT) is a self-administered instrument that includes 10 screening questions tapping alcohol use and alcohol-related consequences in the past 12 months.
Baseline, 4-6 weeks, 3 months, 6 months
Change in Drug Use
Time Frame: Baseline, 4-6 weeks, 3 months, 6 months
The Drug Abuse Screening Test (DAST-10) is a 10-item questionnaire tapping the use of drugs and related health effects and behaviors over the past 12 months.
Baseline, 4-6 weeks, 3 months, 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in General Well Being
Time Frame: Baseline, 4-6 weeks, 3 months, 6 months
The General Well Being Schedule (GWB) is an 18-item, self-administered questionnaire that includes positive and negative questions tapping six dimensions: positive well-being, self-control, vitality, depression, anxiety, and general health. Statements ask participants to indicate feelings in the past 30 days. Lower scores indicate lower overall well-being.
Baseline, 4-6 weeks, 3 months, 6 months
Changes in Health Conditions
Time Frame: Baseline, 4-6 weeks, 3 months, 6 months
The World Health Organization Disability Assessment Schedule (WHODAS) 2.0 is a 12-item questionnaire tapping difficulties due to health conditions. Participants report difficulties in physical, cognitive, and social tasks in the past 30 days. Provided response categories range between 0 (none) and 4 (extreme or cannot do).
Baseline, 4-6 weeks, 3 months, 6 months
Change in Social Support
Time Frame: Baseline, 4-6 weeks, 3 months, 6 months
The Medical Outcomes Study (MOS) Social Support Survey is a 19-item self-administered questionnaire tapping four functional support domains: positive social interaction, emotional/informational support; tangible/instrumental support; and affectionate support. Provided response categories range from "none of the time" to "all of the time"
Baseline, 4-6 weeks, 3 months, 6 months
Changes in Chronic Pain
Time Frame: Baseline, 4-6 weeks, 3 months, 6 months
The Brief Pain Inventory-Short Form (BPI-SF), is a 15-item self-administered questionnaire that assesses the severity and impact of pain.
Baseline, 4-6 weeks, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joseph Schwartz, PhD, Florida State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

September 25, 2025

First Submitted That Met QC Criteria

September 30, 2025

First Posted (Actual)

October 8, 2025

Study Record Updates

Last Update Posted (Actual)

March 5, 2026

Last Update Submitted That Met QC Criteria

March 3, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD - Post Traumatic Stress Disorder

Clinical Trials on Adapted STAIR-NT

Subscribe